Harumi Kato

Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B‐cell lymphoma and suggests patients’ survival benefit from rituximab

Yasuhiro Oki, Kazuhito Yamamoto, Harumi Kato et al. · European Journal Of Haematology · 2008 · 100 citations

Medicine, Hematology, Oncology +14

Gene expression profiling of Epstein–Barr virus‐positive diffuse large B‐cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways

Harumi Kato, Kennosuke Karube, Kazuhito Yamamoto et al. · Cancer Science · 2014 · 72 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma

Takashi Watanabe, Harumi Kato, Yukio Kobayashi et al. · Cancer Science · 2009 · 64 citations · Full text

Medicine, Oncology, Pharmacology +16

Optical Coherence Tomography Findings in Lesions After Sirolimus-Eluting Stent Implantation With Peri-Stent Contrast Staining

Takeshi Tada, Kazushige Kadota, Shingo Hosogi et al. · Circulation Cardiovascular Interventions · 2012 · 49 citations · Full text

Medicine, Cardiology, Biomedical Imaging +16

Phase II study of a salvage regimen using cyclophosphamide, high‐dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B‐cell non‐Hodgkin's lymphoma

Yasuhiro Oki, Michinori Ogura, Harumi Kato et al. · Cancer Science · 2007 · 46 citations · Full text

Medicine, Oncology, Pharmacotherapy +15